Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1981-10-02
1984-05-22
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
544271, 544273, C07D47312, A61K 3152
Patent
active
044501633
ABSTRACT:
The invention relates to a process for the preparation of 1,3,7-trialkyl xanthines, i.e. xanthines completely substituted on the nitrogen atoms, by the N-alkylation of xanthines by phase transfer catalysis. Some of the trialkyl xanthines obtained are new and di(3,7-dimethylxanthin-1-yl)methane is described as a medicament having immunosupressant properties.
REFERENCES:
patent: 631757 (1899-08-01), Fritz
patent: 631760 (1899-08-01), Fritz
patent: 2523496 (1950-09-01), Campbell et al.
patent: 3740433 (1973-06-01), Clody et al.
Klingler; Chemikar-Zeitung; 96, pp. 424-432. (1972).
Gokol; Jour. of Chemical Education, vol. 55, pp. 350-354 (1978).
Chem. Abs. vol. 49:9045h (1954) (Abstract of British Pat. 706424).
Lee Mary C.
Societe d'Assistance Technique pour Produits Nestle S.A.
LandOfFree
Process for the preparation of 1,3,7-trialkyl xanthines and di(3 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for the preparation of 1,3,7-trialkyl xanthines and di(3, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for the preparation of 1,3,7-trialkyl xanthines and di(3 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1478294